Company news

Oncolytics Biotech Inc. news in 2023

Oncolytics Biotech Inc.'s news releases, calls and decks from 2023, newest first.

View company

Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCS

December 7, 2023

Oncolytics Provides Update on Pancreatic Cancer Program for Pelareorep

November 9, 2023

Oncolytics Biotech® and SOLTI Present Further Positive Pelareorep Translational Data at SITC

November 3, 2023

The pancreatic cancer action network selects Oncolytics Biotech® Inc. to receive $5 million Therapeutic Accelerator Award to develop leading-edge treatments

September 26, 2023

Oncolytics Biotech® Reports Second Quarter 2023 Financial Results and Operational Highlights

August 14, 2023

Oncolytics Biotech's® Pelareorep Selected for Inclusion in Precision PromiseSM Pivotal Phase 3 Platform Trial

June 21, 2023

Oncolytics Biotech® Announces Updated Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial that Show Pelareorep Driving Robust Increases in Progression-Free Survival and Confirmed Overall Response Rate

June 4, 2023

Oncolytics Biotech® Announces Positive Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial Demonstrating Pelareorep Drives ≥50% Improvements in ORR and mPFS in an ASCO Annual Meeting Abstract

May 24, 2023

Oncolytics Biotech® Reports First Quarter 2023 Financial Results and Operational Highlights

May 4, 2023

Oncolytics Biotech® Announces Upcoming Oral Presentation on Randomized BRACELET-1 Trial in HR+/HER2- Metastatic Breast Cancer at the ASCO Annual Meeting

April 25, 2023

Oncolytics Biotech® Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders

April 11, 2023

Oncolytics Biotech® Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights

March 2, 2023

Calls in 2023

Decks in 2023